593 results on '"Chen, Ying-Bei"'
Search Results
2. Interferon signaling promotes tolerance to chromosomal instability during metastatic evolution in renal cancer
3. Differential NEUROD1, ASCL1, and POU2F3 Expression Defines Molecular Subsets of Bladder Small Cell/Neuroendocrine Carcinoma With Prognostic Implications
4. L1 Cell Adhesion Molecule (L1CAM) Expression and Molecular Alterations Distinguish Low-Grade Oncocytic Tumor From Eosinophilic Chromophobe Renal Cell Carcinoma
5. Update on Selected High-grade Renal Cell Carcinomas of the Kidney: FH-deficient, ALK-rearranged, and Medullary Carcinomas
6. Immunometabolic coevolution defines unique microenvironmental niches in ccRCC
7. Peyronie disease
8. Condyloma acuminatum
9. Chronic inflammation of the prostate
10. Hypospermatogenesis
11. Cystitis cystica et glandularis
12. Seminal vesicle/ejaculatory duct
13. Basal cell hyperplasia
14. Cowper gland
15. Contributors
16. Urothelial proliferation of uncertain malignant potential
17. Staging for penile squamous cell carcinoma
18. Urothelial carcinoma with sarcomatoid differentiation
19. Fumarate hydratase c.914T > C (p.Phe305Ser) is a pathogenic variant associated with hereditary leiomyomatosis and renal cell cancer syndrome
20. Papillary renal cell carcinoma: a single institutional study of 199 cases addressing classification, clinicopathologic and molecular features, and treatment outcome
21. TERT Copy Number Alterations, Promoter Mutations and Rearrangements in Adrenocortical Carcinomas
22. Long-term Outcomes of Local and Metastatic Small Cell Carcinoma of the Urinary Bladder and Genomic Analysis of Patients Treated With Neoadjuvant Chemotherapy
23. Genomic and Metabolic Hallmarks of SDH- and FH-deficient Renal Cell Carcinomas
24. Author Correction: FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation
25. FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation
26. Spatiotemporal evolution of the clear cell renal cell carcinoma microenvironment links intra-tumoral heterogeneity to immune escape
27. New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia
28. Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia
29. Putative Drivers of Aggressiveness in TCEB1-mutant Renal Cell Carcinoma: An Emerging Entity with Variable Clinical Course
30. Adverse histology, homozygous loss of CDKN2A/B, and complex genomic alterations in locally advanced/metastatic renal mucinous tubular and spindle cell carcinoma
31. Molekularpathologie bei urologischen Tumoren: Empfehlungen der Konsenskonferenz der Internationalen Gesellschaft für Uropathologie (ISUP) 2019
32. Impact of Zone of Origin in Anterior Dominant Prostate Cancer: Long-Term Biochemical Recurrence-Free Survival in an Anatomically Well-Characterized Cohort
33. Clinical and Genomic Characterization of Bladder Carcinomas With Glandular Phenotype
34. Update on Selected High-grade Renal Cell Carcinomas of the Kidney: FH-deficient, ALK-rearranged, and Medullary Carcinomas
35. Imaging features of fumarate hydratase-deficient renal cell carcinomas: a retrospective study
36. Practice Patterns in Reporting Tertiary Grades at Radical Prostatectomy: Survey of a Large Group of Experienced Urologic Pathologists
37. Immunohistochemistry-based assessment of androgen receptor status and the AR-null phenotype in metastatic castrate resistant prostate cancer
38. JAK2/PD-L1/PD-L2 (9p24.1) amplifications in renal cell carcinomas with sarcomatoid transformation: implications for clinical management
39. Distinctive mechanisms underlie the loss of SMARCB1 protein expression in renal medullary carcinoma: morphologic and molecular analysis of 20 cases
40. Mucinous Tubular and Spindle-Cell Carcinoma of the Kidney: Clinical Features, Genomic Profiles, and Treatment Outcomes
41. Metastatic Chromophobe Renal Cell Carcinoma: Presence or Absence of Sarcomatoid Differentiation Determines Clinical Course and Treatment Outcomes
42. Tubulocystic renal cell carcinoma: a distinct clinicopathologic entity with a characteristic genomic profile
43. Recognizing Hereditary Renal Cancers Through the Microscope: A Pathology Update
44. Clinical Utility of Prostate and Tumor Volume-Related Parameters Following Radical Prostatectomy for Localized Prostate Cancer
45. Clinical utility of total length Gleason pattern 4 on biopsy in men with Grade Group 2 prostate cancer
46. Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers: III: Molecular Pathology of Kidney Cancer
47. Tumor Xenografts of Human Clear Cell Renal Cell Carcinoma But Not Corresponding Cell Lines Recapitulate Clinical Response to Sunitinib: Feasibility of Using Biopsy Samples
48. Genomic Characterization of Renal Medullary Carcinoma and Treatment Outcomes
49. Leiomyoma with bizarre nuclei: a morphological, immunohistochemical and molecular analysis of 31 cases
50. Supplementary Table from A Targetable Myeloid Inflammatory State Governs Disease Recurrence in Clear-Cell Renal Cell Carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.